The PCI Center

Filter Your Results

 

News

 

Presentation of Abiomed's Impella Quality Assurance Program Highlights Importance of Treatment Protocols

March 19, 2017 -- Abiomed announced that data from the company's Impella Quality (IQ) Assurance Program, which includes the IQ Database and cVAD Registry were present…

FFR-Guided Acute Complete Revascularization Studied in COMPARE-ACUTE

March 18, 2017 -- Pieter Smits, MD, presented findings from the COMPARE-ACUTE trial at ACC.17, the American College of Cardiology's (ACC) 66th annual scientific sessions i…

DECISION CTO Compares PCI With Optimal Medical Therapy

March 18, 2017 -- The American College of Cardiology announced the presentation of data from the DECISION CTO randomized trial by lead investigator Seung-Jung Park, MD, at the…

Abbott Vascular's 2-Year ABSORB III Data Presented; FDA Issues Warning Letter

March 18, 2017 -- Abbott Vascular announced that data from ABSORB III, the company's United States pivotal trial of its Absorb bioresorbable vascular scaffold, showed…

MATRIX Trial Compares Radial and Femoral Access for PCI

March 18, 2017 -- Alessandro Sciahbasi, MD, revealed findings from the MATRIX study during a featured clinical research presentation at ACC.17, the American College of Ca…

MR-INFORM Evaluates Stress-Perfusion Imaging to Guide Management of Stable CAD

March 17, 2017 -- Findings from the MR-INFORM study of stress-perfusion imaging to guide the management of patients with stable coronary artery disease (CAD) were presented by…

Teleflex's Spectre Guidewire Cleared by FDA

March 15, 2017 -- Teleflex Incorporated announced US Food and Drug Administration 510(k) clearance and the United States commercial launch of the Spectre guidewire. The Spectr…

Q3 Medical Financing Agreement to Support Product Development and Commercialization

March 15, 2017 -- Q3 Medical Devices Limited announced that it has entered into an €28.3-million investment agreement with Boill Holding Group of Shanghai, China. Th…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.